Plasma homocysteine and cognition in elderly patients with dementia or other psychogeriatric diseases

Dementia and Geriatric Cognitive Disorders

Volumn 30, Issue 3, 2010, Pages 198-204

  Nilsson, Karin ^a   Gustafson, Lars ^a   Hultberg, Björn ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cobalamin; Cognition; Creatinine; Cystatin C; Folate; Homocysteine; Psychogeriatric patients; Vascular disease

Indexed keywords

COBALAMIN; CREATININE; CYSTATIN C; FOLIC ACID; HOMOCYSTEINE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD LEVEL; COGNITION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEMENTIA; FEMALE; GERIATRIC DISORDER; GERIATRIC PATIENT; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MINI MENTAL STATE EXAMINATION; PRIORITY JOURNAL; VASCULAR DISEASE; VITAMIN BLOOD LEVEL;

AGED; AGED, 80 AND OVER; COGNITION; COGNITION DISORDERS; CREATININE; DEMENTIA; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; REGRESSION ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED; VASCULAR DISEASES; VITAMIN B 12;

EID: 77956066614     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000319535     Document Type: Article

References (50)

1. Nilsson K, Gustafson L, Fäldt R, Andersson A, Brattström L , Lindgren A, et al: Hyperho-mocysteinemia-a common finding in a psy-chogeriatric population. Eur J Clin Invest 1996; 26: 853-859.
2. 12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol 1998; 55:1449-1455.
3. Lehmann M, Gottfries CG, Regland B: Identification of cognitive impairment in the elderly: homocysteine is an early marker. Dem Geriatr Cogn Disord 1999; 10:12-20.
4. 12 in mild cognitive impairment, Alzheimer's disease and vascular dementia. Am J Clin Nutr 2004; 80:114-122.
5. Refsum H, Smith DA, Ueland PM, Nexö E, Clarke R, McPartlin J, et al: Facts and recommendations about total homocysteine determinations: an expert opinion. Clin Chem 2004; 50:3-32.
6. Brattström L, Lindgren A, Israelsson B, An-dersson A, Hultberg B: Homocysteine and cysteine: determinants of plasma levels in middle-aged and elderly subjects. J Intern Med 1994; 236:633-641.
7. Wald DS, Law M, Morris JK: Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 2002; 325: 1202-1209.
8. Homocysteine Studies Collaboration: Ho-mocysteine and risk of ischemic heart disease and stroke: a metaanalysis. JAMA 2002; 288:2015-2022.
9. Wald DS, Morris JK, Law M, Wald NJ: Folic acid, homocysteine and cardiovascular disease: judging causality in the face of inconclusive trial evidence. BMJ 2006; 333:1114-1117.
10. Castro R, Rivera I, Blom HJ, Jakobs C, Tava-res de Almeida I: Homocysteine metabolism, hyperhomocysteinaemia and vascular disease: an overview. J Inherit Metab Dis 2006; 29:3-20.
11. Nilsson K, Gustafson L, Hultberg B: Plasma homocysteine concentration and its relation to symptoms of vascular disease in psycho-geriatric patients. Dem Geriatr Cogn Disord 2005; 20: 5-41.
12. Nilsson K, Gustafson L, Hultberg B: Plasma homocysteine and vascular disease in elderly patients with psychogeriatric disease. Dem Geriatr Cogn Disord 2006; 21:148-154.
13. Nilsson K, Gustafson L, Hultberg B: Plasma homocysteine, cobalamin/folate status, and vascular disease in a large population of psy-chogeriatric patients. Dem Geriatr Cogn Disord 2006: 22: 358-366.
14. Nilsson K, Gustafson L, Hultberg B: Elevated plasma homocysteine concentration in elderly patients with mental illness is mainly related to the presence of vascular disease and not the diagnosis. Dem Geriatr Cogn Disord 2007; 24:162-168.
15. Mielke MM, Zandi PP: Hematologic risk factors of vascular disease and their relation to dementia. Dement Geriatr Cogn Disord 2006; 21:335-352.
16. Alagiakrishnan A, McCracen P, Feldman H: Treating vascular risk factors and maintaining vascular health: is this the way towards successful cognitive ageing and preventing cognitive decline? Postgrad Med J 2006; 82: 101-105.
17. Qui C, De Ronchi D, Fratiglioni L: The epidemiology of the dementias: an update. Curr Opin Psychiatry 2007; 20:380-385.
18. Morris MS, Jacques PF, Rosenberg IH, Selhub J: Hyperhomocysteinemia associated with poor recall in the third National Health and Nutrition Examination Survey. Am J Clin Nutr 2001; 73: 927-933.
19. Dufouil C, Alperovitch A, Ducros V, Tzourio C: Homocysteine, white matter hyperintensities, and cognition in healthy elderly people. Ann Neurol 20 03; 53: 214-221.
20. Tucker KL, Qiao N, Scott T, Rosenberg I, Spiro A: High homocysteine and low B vitamins predict cognitive decline in aging men: the Veteran Affairs Normative Aging Study. Am J Clin Nutr 2005; 82: 627-6 35.
21. Ravaglia G, Forti P, Maioli F, Martelli M, S er vadei L , Br u net ti N, Porc ellin i E , Lica stro F: Homocysteine and folate as risk factors for dementia and Alzheimeŕs disease. Am J Clin Nutr 2005; 82: 636-643.
22. Schafer JH, Glass TA, Bolla KI, Mintz M, Jedlicka AE, Schwartz BS: Homocysteine and cognitive function in a population-based study of older adults. J Am Geriatr Soc 2005; 53: 381-388.
23. McCaddon A, Hudson P, Davies G, Hughes A, Williams JH, Wilkinson C: Homocysteine and cognitive decline in healthy elderly. Dem Geriatr Cogn Disord 2001; 12:309-313.
24. Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D'Agostino RB, Wilson PWF, Wolf PA: Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002; 346: 476-483.
25. Nurk E, Refsum H, Tell GS, Engedal K, Vollset SE, Ueland PM, et al: Plasma total homocysteine and memory in the elderly: the Hordaland Homocysteine Study. Ann Neurol 2005; 58: 847-857.
26. Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Jolles J, Clarke R, Breteler MM: Homocysteine and cognitive function in the elderly: the Rotterdam Scan Study. Neurology 2002; 59: 1375-1380.
27. Ravaglia G , Forti P, Maioli F, Muscari A , Sacchetti L, Arnone G, Nativio V, Talerico T, Mariani E: Homocysteine and cognitive function in healthy community dwellers in Italy. Am J Clin Nutr 2003; 77:668-673.
28. Miller JW, Green R, Ramos MI, Allen LH, Mungas DM, Jagust WJ, Haan MN: Homocysteine and cognitive function in the Sacramento Area Latino Study on aging. Am J Clin Nutr 2003; 78: 441-417.
29. Elias MF, Sullivan LM, D'Agostino RB, Elias PK, Jacques PF, Selhub J, Seshadri S, Au R, Beiser A, Wolf PA: Homocysteine and cognitive performance in the Framingham offspring study: age is important. Am J Epidemiol 2005; 162:644-653.
30. 12 blood levels in relation to cognitive performance: the Maine-Syracuse study. Psychosom Med 2006; 68:547-554.
31. 12 , and folic acid and the risk of cognitive decline in old age: the Leiden 85-Plus Study. Am J Clin Nutr 2005; 82: 866-871.
32. 12 , folate, homocysteine and dementia: are they really related? Arch Gerontol Geriatr 2005; 40: 139-146.
33. Kalmijn S, Launer LJ, Lindemans J, Bots ML, Hofman A, Breteler MM: Total homocysteine and cognitive decline in a communitybased sample of elderly subjects: the Rotterdam Study. Am J Epidemiol 1999; 150: 283-289.
34. Luchsinger JA, Tang M-X, Shea S, Miller J, Green R, Mayeaux R: Plasma homocysteine levels and risk of Alzheimer disease. Neurology 2004; 62: 1972-1976 .
35. 12, and folic acid supplementation and cognitive function: a systematic review of randomized trials. Arch Intern Med 2007; 167: 21-30.
36. Gillette-Guyonnet S, Abellan Van Kan G, Andrieu S, Barberger-Gateau P, Berr C , Bonnefoy MD, et al: IANA task force on nutrition and cognitive decline with aging. J Nutr Health Aging 2007; 11:132-152.
37. 12, folate and cognitive functions: a systematic and critical review of the literature. J Clin Pract 2009; 63:1061-1067.
38. Kang JH, Cook N, Manson J, Buring JE, Albert CM, Grodstein F: A trial of B vitamins and cognitive function among women at risk of cardiovascular disease. Am J Clin Nutr 2008; 88:1602-1610.
39. Durga J, van Boxtel MP, Schouten EG, Kok FJ, Jolles J, Katan MB, Verhoef P: Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled tria l. Lancet 20 07; 369: 208-216.
40. Nilsson K, Gustafson L, Hultberg B: Association between plasma homocysteine levels and mortality in elderly patients with mental illness. Dement Geriatr Cogn Disord 2009; 27:579-583.
41. Folstein MF, McHugh PR: Minimental state: a practical method for grading the state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198 .
42. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, American Psychiatric Association, 1994.
43. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC: Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International work shop. Neurology 1993; 43: 250-260.
44. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan M: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Workgroup under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984; 34: 939-944.
45. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E: Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999; 56: 303-308.
46. Andersson A, Isaksson A, Brattström L, Hultberg B: Homocysteine and other thiols determined in plasma by HPLC and thiolspecific postcolumn derivatization. Clin Chem 1993; 39:1590-1597.
47. Wright CB, Lee HS, Paik MC, Stabler SP, Allen RH, Sacco RL: Total homocysteine and cognition in a triethnic cohort: the Northern Manhattan study. Neurology 2004; 63: 254-260.
48. Sala I, Sanchez-Saudinos MB, Molina-Porcel L, Lazaro E, Gich I, Clarimon J, et al: Homocysteine and cognitive impairment. Dement Geriatr Cogn Disord 2008; 26: 506-512.
49. 12 , folate and lipids in patients with Alzheimer disease. Dement Geriatr Cogn Disord 20 08; 26: 384-390.
50. Obeid R, McCaddon A, Herrmann W: The role of hyperhomocysteinemia and B-vitamin deficiency in neurological and psychiatric diseases Clin Chem Lab Med 2007; 45: 1590-1606.